SAN CARLOS, Calif. & LISBON, Portugal--March 7, 2024--CuraSen Therapeutics, Inc., a clinical-stage company developing small molecule therapies to treat neurodegenerative disease, announced that it will present additional positive Phase 2a...
Jeff Collins will serve as a judge in the Commercializing Innovation competition at the Wake Forest Business School in Winston-Salem, NC
News | 04. 24. 2008
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.